» Articles » PMID: 36233048

Celiac Disease and Possible Dietary Interventions: From Enzymes and Probiotics to Postbiotics and Viruses

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Oct 14
PMID 36233048
Authors
Affiliations
Soon will be listed here.
Abstract

Celiac Disease (CeD) is a chronic small intestinal immune-mediated enteropathy caused by the ingestion of dietary gluten proteins in genetically susceptible individuals. CeD is one of the most common autoimmune diseases, affecting around 1.4% of the population globally. To date, the only acceptable treatment for CeD is strict, lifelong adherence to a gluten-free diet (GFD). However, in some cases, GFD does not alter gluten-induced symptoms. In addition, strict adherence to a GFD reduces patients' quality of life and is often a socio-economic burden. This narrative review offers an interdisciplinary overview of CeD pathomechanism and the limitations of GFD, focusing on current research on possible dietary interventions. It concentrates on the recent research on the degradation of gluten through enzymes, the modulation of the microbiome, and the different types of "biotics" strategies, from probiotics to the less explored "viromebiotics" as possible beneficial complementary interventions for CeD management. The final aim is to set the context for future research that may consider the role of gluten proteins and the microbiome in nutritional and non-pharmacological interventions for CeD beyond the sole use of the GFD.

Citing Articles

Editorial: Gut microbiota and immunity in health and disease: dysbiosis and eubiosis's effects on the human body.

Dodero V, Morre S, Behzadi P Front Immunol. 2025; 15:1536258.

PMID: 39742257 PMC: 11685867. DOI: 10.3389/fimmu.2024.1536258.


Gluten Unraveled: Latest Insights on Terminology, Diagnosis, Pathophysiology, Dietary Strategies, and Intestinal Microbiota Modulations-A Decade in Review.

Stanciu D, Staykov H, Dragomanova S, Tancheva L, Pop R, Ielciu I Nutrients. 2024; 16(21).

PMID: 39519469 PMC: 11547711. DOI: 10.3390/nu16213636.


Exploring substrate-microbe interactions: a metabiotic approach toward developing targeted synbiotic compositions.

Speckmann B, Ehring E, Hu J, Rodriguez Mateos A Gut Microbes. 2024; 16(1):2305716.

PMID: 38300741 PMC: 10841028. DOI: 10.1080/19490976.2024.2305716.


The Gliadin Hydrolysis Capacity of , , and and Their Protective Effects on Caco-2 Cells against Gliadin-Induced Inflammatory Responses.

Ramedani N, Seidita A, Asri N, Azimirad M, Yadegar A, Jahani-Sherafat S Nutrients. 2023; 15(12).

PMID: 37375673 PMC: 10301210. DOI: 10.3390/nu15122769.


The protective role of GG postbiotic on the alteration of autophagy and inflammation pathways induced by gliadin in intestinal models.

Furone F, Bellomo C, Carpinelli M, Nicoletti M, Hewa-Munasinghege F, Mordaa M Front Med (Lausanne). 2023; 10:1085578.

PMID: 37215707 PMC: 10192745. DOI: 10.3389/fmed.2023.1085578.


References
1.
Laterza L, Rizzatti G, Gaetani E, Chiusolo P, Gasbarrini A . The Gut Microbiota and Immune System Relationship in Human Graft-versus-Host Disease. Mediterr J Hematol Infect Dis. 2016; 8(1):e2016025. PMC: 4848019. DOI: 10.4084/MJHID.2016.025. View

2.
Severance E, Yolken R, Eaton W . Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophr Res. 2014; 176(1):23-35. PMC: 4294997. DOI: 10.1016/j.schres.2014.06.027. View

3.
Rubio R, Jofre A, Martin B, Aymerich T, Garriga M . Characterization of lactic acid bacteria isolated from infant faeces as potential probiotic starter cultures for fermented sausages. Food Microbiol. 2013; 38:303-11. DOI: 10.1016/j.fm.2013.07.015. View

4.
Lammers K, Lu R, Brownley J, Lu B, Gerard C, Thomas K . Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology. 2008; 135(1):194-204.e3. PMC: 2653457. DOI: 10.1053/j.gastro.2008.03.023. View

5.
Herrera M, Zamarreno F, Costabel M, Ritacco H, Hutten A, Sewald N . Circular dichroism and electron microscopy studies in vitro of 33-mer gliadin peptide revealed secondary structure transition and supramolecular organization. Biopolymers. 2013; 101(1):96-106. DOI: 10.1002/bip.22288. View